[1] CEOLIN L,DUVAL M,BENINI AF,et al.Medullary thyroid carcinoma beyond surgery:Advances,challenges,and perspectives[J].Endocr Relat Cancer,2019,26(9):R499-R518.
[2] GOSNELL JE,DUH QY.Medullary thyroid carcinoma-We should do better[J].JAMA Surg,2018,153(1):59.
[3] HAMDY O,AWNY S,METWALLY IH.Medullary thyroid cancer:Epidemiological pattern and factors contributing to recurrence and metastasis[J].Ann R Coll Surg Engl,2020,102(7):499-503.
[4] HASSAN A,SIDDIQUE M,RIAZ S,et al.Medullary thyroid carcinoma:Prognostic variables and tumour markers affecting survival[J].J Ayub Med Coll Abbottabad,2018,30(Suppl 1):S627-S632.
[5] ILANCHEZHIAN M,KHAN S,OKAFOR C,et al.Update on the treatment of medullary thyroid carcinoma in patients with multiple endocrine neoplasia type 2[J].Horm Metab Res,2020,52(8):588-597.
[6] WELLL SA,ASA SL,DRALLE H,et al.Revised american thyroid association guidelines for the management of medullary thyroid carcinoma[J].Thyroid,2015,25(6):567-610.
[7] GUO QQ,ZHANG SH,NIU LJ,et al.Comprehensive evaluation of medullary thyroid carcinoma before surgery[J].Chin Med J(Engl),2019,132(7):834-841.
[8] BALACHANDRAN VP,GONEN M,SMITH JJ,et al.Nomograms in oncology:More than meets the eye[J].Lancet Oncol,2015,16(4):e173-180.
[9] MORENO L,GUO D,IRWIN MS,et al.A nomogram of clinical and biologic factors to predict survival in children newly diagnosed with high-risk neuroblastoma:An international neuroblastoma risk group project[J].Pediatr Blood Cancer,2021,68(3):e28794.
[10] LI C,XU F,HUANG Q,et al.Nomograms for differentiated thyroid carcinoma patients based on the eighth AJCC staging and competing risks model[J].JNCI Cancer Spectr,2021,5(3):pkab038.
[11] FAN W,XIAO C,WU F.Analysis of risk factors for cervical lymph node metastases in patients with sporadic medullary thyroid carcinoma[J].J Int Med Res,2018,46(5):1982-1989.
[12] OH HS,KWON H,SONG E,et al.Preoperative clinical and sonographic predictors for lateral cervical lymph node metastases in sporadic medullary thyroid carcinoma[J].Thyroid,2018,28(3):362-368.
[13] AUBERT S,BERDELOU A,GNEMMI V,et al.Large sporadic thyroid medullary carcinomas:Predictive factors for lymph node involvement[J].Virchows Arch,2018,472(3):461-468.
[14] PAZAITOU-PANAYIOTOU K,CHRISOULIDOU A,MANDANAS S,et al.Predictive factors that influence the course of medullary thyroid carcinoma[J].Int J Clin Oncol,2014,19(3):445-451.
[15] MACHENS A,HAUPTMANN S,DRALLE H.Increased risk of lymph node metastasis in multifocal hereditary and sporadic medullary thyroid cancer[J].World J Surg,2007,31(10):1960-1965.
[16] ESFANDIARI NH,HUGHES DT,YIN H,et al.The effect of extent of surgery and number of lymph node metastases on overall survival in patients with medullary thyroid cancer[J].J Clin Endocrinol Metab,2014,99(2):448-454.
[17] CHEN L,WANG Y,ZHAO K,et al.Postoperative nomogram for predicting cancer-specific and overall survival among patients with medullary thyroid cancer[J].Int J Endocrinol,2020,2020:8888677.
[18] YAN D,ZHANG B,LI Z,et al.Cervical lymph node metastasis in medullary thyroid carcinoma[J].Chinese Journal of Otorhinolayngology Head and Neck Surgery,2015,50(4):290-294.
[19] BIBI K,SHAH MH.Study of essential and toxic metal imbalances in the scalp hair of thyroid cancer patients in comparison with healthy donors[J].Biol Trace Elem Res,2021,199(2):500-512.
[20] EISSA MS,ABDELLATEIF MS,ELESAWY YF,et al.Obesity and waist circumference are possible risk factors for thyroid cancer:Correlation with different ultrasonography criteria[J].Cancer Manag Res,2020,12:6077-6089.
[21] YE L,ZHOU X,LU J,et al.Combining serum calcitonin,carcinoembryonic antigen,and neuron-specific enolase to predict lateral lymph node metastasis in medullary thyroid carcinoma[J].J Clin Lab Anal,2020,34(7):e23278.